Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Standardized vs Conventional Oxytocin for Cesarean Delivery
NCT01549223Phase 4Completed
- Sponsor
- Brigham and Women's Hospital
- Start
- Apr 2011
- Primary completion
- Jan 2012
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of oxytocin in uterine atony (2 arms), sponsored by Brigham and Women's Hospital. Primary endpoint: Amount of Oxytocin to Obtain Satisfactory Uterine Tone. Started Apr 2011; status: completed.
02
Drugs
oxytocin
03
Conditions
uterine atony
Beyond the preview
Go deeper on NCT01549223.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01549223.